iShares LifePath Target Date 2055 ETF
ITDG
2 hedge funds and large institutions have $320K invested in iShares LifePath Target Date 2055 ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
0.79% less ownership
Funds ownership: 2.33% → 1.54% (-0.79%)
12% less capital invested
Capital invested by funds: $363K → $320K (-$43K)
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$295K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$349K |
| 2 |
HCA
Heck Capital Advisors
Rhinelander,
Wisconsin
|
-$12.1K |
| 3 |
Morgan Stanley
New York
|
-$39 |
ITDG Hedge Fund Activity: Q2 2025 in Review
2 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in iShares LifePath Target Date 2055 ETF (ITDG) for Q2 2025, worth a combined $320K — down 12% from $363K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ITDG and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $295K. The largest seller was Citadel Advisors, exiting entirely with an estimated $349K sold.
- 2 institutional investors held iShares LifePath Target Date 2055 ETF (ITDG) as of Q2 2025, down from 4 in Q1 2025.
- Funds reported $320K of iShares LifePath Target Date 2055 ETF stock for Q2 2025, down 12% quarter-over-quarter.
- 1 fund opened new iShares LifePath Target Date 2055 ETF positions in Q2 2025 and 3 closed out, a net change of -2 holders.
- The largest iShares LifePath Target Date 2055 ETF buyer in Q2 2025 was Susquehanna International Group, an estimated $295K added.
- The largest iShares LifePath Target Date 2055 ETF seller in Q2 2025 was Citadel Advisors, an estimated $349K sold.
Based on aggregated 13F filings for Q2 2025.